mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.003 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.004 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |